TrialNaunyn-Schmiedeberg's archives of pharmacology2025

Ranolazine effectively improves clinical symptoms in patients with slow flow coronary arteries: a randomized, double-blind, placebo-controlled clinical trial.

Bahram Shahri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.